The groundbreaking neuroscience research happening at executive-level GSL investor Washington University — where some of the world’s first clinical trials in Alzheimer’s prevention are taking place — is attracting national attention. CBS News spent time in St. Louis talking to Dr. Randall Bateman, the neurologist leading these international trials, about the success he’s seeing in treating mild Alzheimer’s with medication.
“Now we have a chance to change the course of the disease in a way we’ve never been able to do before,” Bateman said.
The Bottom Line: The prevention, treatment, and cure for a major disease that affects people around the globe will likely be found in our own backyard. While Bateman’s clinical trial specifically targets early-onset patients, it has far-reaching implications for everyone affected by the disease.
World class research and medicine is happening here. When we prioritize, fund, and support it, we not only contribute to medical innovation that benefits us individually and collectively, we contribute to St. Louis’ robust innovation ecosystem — and our regional economic growth.